학술논문

Head and neck surgical oncology in the time of a pandemic: Subsite‐specific triage guidelines during the COVID‐19 pandemic
Document Type
article
Source
Head & Neck. 42(6)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Patient Safety
Dental/Oral and Craniofacial Disease
Clinical Research
Rare Diseases
Prevention
Cancer
Good Health and Well Being
Betacoronavirus
COVID-19
Cancer Care Facilities
Communicable Disease Control
Consensus
Coronavirus Infections
Female
Head and Neck Neoplasms
Humans
Male
Occupational Health
Outcome Assessment
Health Care
Pandemics
Patient Selection
Pneumonia
Viral
Practice Guidelines as Topic
SARS-CoV-2
Surgical Oncology
Triage
United States
oncology
otolaryngology
MD Anderson Head and Neck Surgery Treatment Guidelines Consortium
Consortium members
Dentistry
Otorhinolaryngology
Clinical sciences
Language
Abstract
BackgroundCOVID-19 pandemic has strained human and material resources around the world. Practices in surgical oncology had to change in response to these resource limitations, triaging based on acuity, expected oncologic outcomes, availability of supportive resources, and safety of health care personnel.MethodsThe MD Anderson Head and Neck Surgery Treatment Guidelines Consortium devised the following to provide guidance on triaging head and neck cancer (HNC) surgeries based on multidisciplinary consensus. HNC subsites considered included aerodigestive tract mucosa, sinonasal, salivary, endocrine, cutaneous, and ocular.RecommendationsEach subsite is presented separately with disease-specific recommendations. Options for alternative treatment modalities are provided if surgical treatment needs to be deferred.ConclusionThese guidelines are intended to help clinicians caring for patients with HNC appropriately allocate resources during a health care crisis, such as the COVID-19 pandemic. We continue to advocate for individual consideration of cases in a multidisciplinary fashion based on individual patient circumstances and resource availability.